These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11428240)

  • 21. Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defenses.
    Torres L; Tang Q
    Virol Sin; 2014 Dec; 29(6):343-52. PubMed ID: 25501994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.
    Xu S; Schafer X; Munger J
    J Virol; 2016 May; 90(9):4346-4356. PubMed ID: 26889030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts.
    Cinatl J; Kotchetkov R; Weimer E; Blaheta RA; Scholz M; Vogel JU; Gümbel HO; Doerr HW
    J Med Virol; 2000 Mar; 60(3):313-23. PubMed ID: 10630964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome.
    Fortunato EA; Sanchez V; Yen JY; Spector DH
    J Virol; 2002 Jun; 76(11):5369-79. PubMed ID: 11991965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection.
    Johnson RA; Huong SM; Huang ES
    Antiviral Res; 1999 Apr; 41(3):101-11. PubMed ID: 10320043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisense oligonucleotide ISIS 2922 targets IE-expression and prevents HCMV-IE-induced suppression of TSP-1 and TSP-2 expression.
    Margraf S; Bittoova M; Vogel JU; Kotchekov R; Doerr HW; Cinatl J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1425-8. PubMed ID: 11563036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches for the generation of new anti-cytomegalovirus agents: identification of protein-protein interaction inhibitors and compounds against the HCMV IE2 protein.
    Mercorelli B; Gribaudo G; Palù G; Loregian A
    Methods Mol Biol; 2014; 1119():349-63. PubMed ID: 24639231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.
    Oduro JD; Uecker R; Hagemeier C; Wiebusch L
    J Virol; 2012 Sep; 86(17):9369-83. PubMed ID: 22718829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies.
    Yaiw KC; Mohammad AA; Taher C; Wilhelmi V; Davoudi B; Strååt K; Assinger A; Ovchinnikova O; Shlyakhto E; Rahbar A; Koutonguk O; Religa P; Butler L; Khan Z; Streblow D; Pernow J; Söderberg-Nauclér C
    Basic Res Cardiol; 2014 Mar; 109(2):401. PubMed ID: 24442486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives.
    Mercorelli B; Lembo D; Palù G; Loregian A
    Pharmacol Ther; 2011 Sep; 131(3):309-29. PubMed ID: 21570424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
    Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
    J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region.
    Azad RF; Driver VB; Tanaka K; Crooke RM; Anderson KP
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1945-54. PubMed ID: 8239610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytomegalovirus immediate early proteins and cell growth control.
    Castillo JP; Kowalik TF
    Gene; 2002 May; 290(1-2):19-34. PubMed ID: 12062798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.
    Muganda P; Carrasco R; Qian Q
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):321-31. PubMed ID: 9593583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 5' Untranslated Region of the Major Immediate Early mRNA Is Necessary for Efficient Human Cytomegalovirus Replication.
    Arend KC; Lenarcic EM; Moorman NJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exon 3 of the human cytomegalovirus major immediate-early region is required for efficient viral gene expression and for cellular cyclin modulation.
    White EA; Spector DH
    J Virol; 2005 Jun; 79(12):7438-52. PubMed ID: 15919900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action.
    Evers DL; Chao CF; Wang X; Zhang Z; Huong SM; Huang ES
    Antiviral Res; 2005 Dec; 68(3):124-34. PubMed ID: 16188329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK.
    Hutterer C; Wandinger SK; Wagner S; Müller R; Stamminger T; Zeitträger I; Godl K; Baumgartner R; Strobl S; Marschall M
    Antiviral Res; 2013 Aug; 99(2):139-48. PubMed ID: 23648710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.